GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 22 filers reported holding GAIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,929,985 | -21.2% | 588,410 | +7.7% | 0.11% | -4.3% |
| Q2 2023 | $2,448,589 | -7.1% | 546,560 | 0.0% | 0.12% | -19.6% |
| Q1 2023 | $2,634,419 | +54.0% | 546,560 | 0.0% | 0.14% | +21.2% |
| Q4 2022 | $1,710,732 | -3.9% | 546,560 | 0.0% | 0.12% | -6.3% |
| Q3 2022 | $1,781,000 | -9.5% | 546,560 | 0.0% | 0.13% | -17.6% |
| Q2 2022 | $1,967,000 | -12.0% | 546,560 | 0.0% | 0.15% | +7.7% |
| Q1 2022 | $2,236,000 | -24.7% | 546,560 | 0.0% | 0.14% | -16.5% |
| Q4 2021 | $2,968,000 | -27.1% | 546,560 | 0.0% | 0.17% | -37.7% |
| Q3 2021 | $4,069,000 | -25.6% | 546,560 | 0.0% | 0.27% | -20.4% |
| Q2 2021 | $5,466,000 | -33.0% | 546,560 | 0.0% | 0.34% | -39.6% |
| Q1 2021 | $8,155,000 | – | 546,560 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 90,000 | $295,200 | 0.31% |
| Greenlight Capital | 588,410 | $1,929,985 | 0.11% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $190,568 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,100 | $148,903 | 0.00% |
| Householder Group Estate & Retirement Specialist, LLC | 2,500 | $8,200 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HM PAYSON & CO | 1,000 | $3,280 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,937 | $6,257 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 151,476 | $489,355 | 0.00% |
| MORGAN STANLEY | 1,300 | $4,264 | 0.00% |